MS140

 CAS No.: 2229974-83-6  Cat No.: BP-400149  Purity: ≥95% 4.5  

MS140, also known as XY028-140, is a cereblon-mediated PROTAC degrader targeting CDK4 and CDK6. Public sources describe it as a potent and selective CDK4/CDK6 degrader that reduces CDK4 and CDK6 protein levels and suppresses RB-E2F signaling, while detailed structural binding-site information remains limited in accessible summaries. In PROTAC design, the CDK-recognition element binds the kinase targets, the linker positions the degrader, and the cereblon ligand recruits CRL4-cereblon ubiquitination machinery. Mechanistically, MS140 induces proximity between CDK4 or CDK6 and cereblon, supporting ubiquitination and proteasome-dependent degradation of the kinases. It is useful for studying cell-cycle regulation, CDK4/CDK6 target validation, degradation versus kinase inhibition, selectivity among CDK-family proteins, and optimization of cereblon-recruiting kinase degraders that modulate RB-E2F pathway activity through protein depletion.

MS140

Structure of 2229974-83-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC
Molecular Formula
C39H40N10O7
Molecular Weight
760.80
Appearance
Solid Powder

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
≥95%
Solubility
Soluble in DMSO
Appearance
Solid Powder
Storage
Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)
IUPACName
4-[[2-[4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazin-1-yl]-2-oxoethyl]amino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
Synonyms
4-((2-(4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-2-oxoethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; 1H-Isoindole-1,3(2H)-dione, 4-[[2-[4-[6-[(6-acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinyl]-2-oxoethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-; 4-[[2-[4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinyl]-2-oxoethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione; XY028-140
Density
1.482±0.06 g/cm3
InChI Key
IWFNIKIERKCKFZ-UHFFFAOYSA-N
InChI
InChI=1S/C39H40N10O7/c1-21-26-19-42-39(45-34(26)48(23-6-3-4-7-23)37(55)32(21)22(2)50)43-29-12-10-24(18-41-29)46-14-16-47(17-15-46)31(52)20-40-27-9-5-8-25-33(27)38(56)49(36(25)54)28-11-13-30(51)44-35(28)53/h5,8-10,12,18-19,23,28,40H,3-4,6-7,11,13-17,20H2,1-2H3,(H,44,51,53)(H,41,42,43,45)
SMILES
CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C(=O)CNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C8CCCC8)C(=O)C
Mechanism

Target: MS140, also known as XY028-140, targets CDK4 and CDK6 kinases.

Binding site: Its CDK ligand binds the ATP-binding catalytic pockets of CDK4 and CDK6.

Mechanism of action: MS140 is a CRBN-mediated CDK4/6 PROTAC designed to degrade both CDK4 and CDK6 and thereby suppress RB-E2F pathway signaling through protein removal. The compound links a CDK4/6-recognition element to a cereblon-binding ligand, inducing formation of ternary complexes that promote ubiquitination of CDK4 and CDK6. Subsequent proteasomal degradation reduces target abundance in a dose- and time-dependent manner. MS140 is useful for studying cell-cycle control, degradation kinetics, CDK4 versus CDK6 contribution, and differences between CDK4/6 inhibitor exposure and degradation-mediated pathway suppression.

Applications

• PROTAC-Mediated Targeted Degradation: MS140 is designed to facilitate the targeted degradation of specific proteins, offering researchers a powerful tool for probing protein function and validating therapeutic targets. By leveraging the ubiquitin-proteasome system, MS140 enables the selective removal of proteins, providing insights into cellular processes and disease mechanisms.

• Protein Interaction Studies: Utilizing MS140 in protein interaction studies allows researchers to dissect complex signaling pathways. By selectively degrading proteins of interest, MS140 aids in unraveling protein networks and interactions, enhancing the understanding of cellular dynamics and function.

• Drug Discovery and Development: MS140 serves as a pivotal asset in drug discovery, enabling the identification of novel therapeutic targets through targeted protein degradation. Its application in preclinical research accelerates the validation of potential drug candidates by elucidating the role of specific proteins in disease pathways.

• Mechanistic Pathway Analysis: Employing MS140 in mechanistic pathway analysis assists scientists in elucidating the functional roles of proteins within biological systems. By inducing protein degradation, MS140 provides a strategic approach to investigate cellular responses and regulatory mechanisms at a molecular level.

1. Imaging and Fluorescence Quantification in Caenorhabditis elegans with Flow Vermimetry and Automated Microscopy
Elissa Tjahjono, Alexey V Revtovich, Natalia V Kirienko Bio Protoc . 2021 May 20;11(10):e4024. doi: 10.21769/BioProtoc.4024.
Gene activation and cellular biomarkers are commonly monitored using fluorescent signals from transgenic reporters or dyes. These quantifiable markers are critical for biological research and serve as an incredibly powerful tool, even more so when combined with high-throughput screening.Caenorhabditis elegansis a particularly useful model in this regard, as it is inexpensive to grow in vast numbers, has a rapid generation time, is optically transparent, and can readily fit within 384-well plates. However, fluorescence quantification in worms is often cumbersome. Quantification is frequently performed using laborious, low-throughput, bias-prone methods that measure fluorescence in a comparatively small number of individual worms. Here we describe two methods, flow vermimetry using a COPAS BioSorter and an automated imaging platform and analysis pipeline using a Cytation5 multimode plate reader and image analysis software, that enable high-throughput, high-content screening inC. elegans. Flow vermimetry provides a better signal-to-noise ratio with fewer processing steps, while the Cytation5 provides a convenient platform to image samples across time. Fluorescence values from the two methods show strong correlation. Either method can be easily extended to include other parameters, such as the measurement of various metabolites, worm viability, and other aspects of cell physiology. This broadens the utility of the system and allows it to be used for a wide range of molecular biological purposes.
2. The sugar-insensitive1 (sis1) mutant of Arabidopsis is allelic to ctr1
S I Gibson, R J Laby, D Kim Biochem Biophys Res Commun . 2001 Jan 12;280(1):196-203. doi: 10.1006/bbrc.2000.4062.
Soluble sugar levels affect a diverse array of plant developmental processes. For example, exposure to high levels of glucose or sucrose inhibits early seedling development of Arabidopsis thaliana (L.) Heynh. Media-shift experiments indicate that Arabidopsis seedlings lose their sensitivity to the inhibitory effects of high sugar levels on early development within approximately two days after the start of imbibition. The sugar-insensitive1 (sis1) mutant of Arabidopsis was isolated by screening for plants that are insensitive to the inhibitory effects of high concentrations of sucrose on early seedling development. The sis1 mutant also displays glucose and mannose resistant phenotypes and has an osmo-tolerant phenotype during early seedling development. The sis1 mutant is resistant to the negative effects of paclobutrazol, an inhibitor of gibberellin biosynthesis, on seed germination. Characterization of the sis1 mutant revealed that it is allelic to ctr1, a previously identified mutant with a constitutive response to ethylene.
3. Structure and assembly of the influenza A virus ribonucleoprotein complex
Wenjie Zheng, Yizhi Jane Tao FEBS Lett . 2013 Apr 17;587(8):1206-14. doi: 10.1016/j.febslet.2013.02.048.
The genome of influenza A viruses consists of eight segments of single-stranded, negative-sense RNA that are encapsidated as individual rod-shaped ribonucleoprotein complexes (RNPs). Each RNP contains a viral RNA, a viral polymerase and multiple copies of the viral nucleoprotein (NP). Influenza A virus RNPs play important roles during virus infection by directing viral RNA replication and transcription, intracellular transport of the viral RNA, gene reassortment as well as viral genome packaging into progeny particles. As a unique genomic entity, the influenza A virus RNP has been extensively studied since the 1960s. Recently, exciting progress has been made in studying the RNP structure and its assembly, leading to a better understanding of the structural basis of various RNP functions.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket